Anti-CD69 Autoantibodies Cross-React with Low Density Lipoprotein Receptor-Related Protein 2 in Systemic Autoimmune Diseases1

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Immunology

• Publication date

  2001-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.166.2.1360PMID 11145721
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis.

  1999cited by this paper
• Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases.

  1999cited by this paper
• Autoantibodies to T cell co-stimulatory molecules in systemic autoimmune diseases

  1999cited by this paper
• Molecular mimicry and autoimmune disease

  1998cited by this paper
• Participation of the CD69 Antigen in the T‐Cell Activation Process of Patients with Systemic Lupus Erythematosus

  1998cited by this paper
• The function of costimulatory molecules and the development of IL-4-producing T cells.

  1997cited by this paper
• CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity

  1997influential reference
• Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.

  1997cited by this paper
• CD69 expression reliably predicts the anti-CD3-induced proliferative response of lymphocytes from human immunodeficiency virus type 1-infected patients

  1997cited by this paper
• Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1.

  1997cited by this paper
• The CD69 activation pathway in rheumatoid arthritis synovial fluid T cells.

  1996influential reference
• Cell-type specificity of anti-CD45 autoantibodies in systemic lupus erythematosus.

  1996cited by this paper
• CD69 on synovial T cells in rheumatoid arthritis correlates with disease activity.

  1996cited by this paper
• Expression of the early lymphocyte activation antigen CD69, a C‐type lectin, is regulated by mRNA degradation associated with AU‐rich sequence motifs

  1995cited by this paper
• Characterization and regulation of CD69 expression on rheumatoid arthritis synovial fluid T cells.

  1995cited by this paper
• Transcriptional Regulation of the Gene Encoding the Human C-type Lectin Leukocyte Receptor AIM/CD69 and Functional Characterization of Its Tumor Necrosis Factor-α-responsive Elements (*)

  1995cited by this paper
• Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors

  1994cited by this paper
• The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells.

  1994cited by this paper
• Activation of naive, memory and effector T cells.

  1994cited by this paper
• Activation-induced apoptosis in lymphocytes.

  1994cited by this paper
• Transcriptional regulation of interleukin‐2 gene expression by CD69‐generated signals

  1993cited by this paper
• Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes.

  1993cited by this paper
• Analysis of glomeruli-eluted Gp330 autoantibodies and of Gp330 antigen of Heymann nephritis.

  1993cited by this paper
• Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain.

  1993cited by this paper
• Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors

  1993cited by this paper
• Molecular characterization of the early activation antigen CD69: A type II membrane glycoprotein related to a family of natural killer cell activation antigens

  1993cited by this paper
• Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway.

  1992cited by this paper
• Tumor necrosis factor‐α production induced in T lymphocytes through the AIM/CD69 activation pathway

  1992cited by this paper
• Pathogenetic significance of anti-lymphocyte autoantibodies in systemic lupus erythematosus.

  1992cited by this paper
• Preferential involvement of a phospholipase A2-dependent pathway in CD69-mediated platelet activation.

  1992cited by this paper
• Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance.

  1992cited by this paper
• CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression.

  1991cited by this paper
• Induction of autoreactive B cells allows priming of autoreactive T cells

  1991cited by this paper
• Autoantibodies specific for different isoforms of CD45 in systemic lupus erythematosus

  1990cited by this paper
• Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

  1990cited by this paper
• T cell activation via Leu-23 (CD69).

  1989cited by this paper
• Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor.

  1989cited by this paper
• Expression and function of AIM, an activation inducer molecule of human lymphocytes, is dependent on the activation of protein kinase C

  1989cited by this paper
• Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.

  1988cited by this paper
• An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein.

  1988cited by this paper
• Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes

  1988cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Isolation and characterization of a complementary DNA expressing human U1 small nuclear ribonucleoprotein C polypeptide.

  1988cited by this paper
• Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen

  1988cited by this paper
• Molecular mimicry and autoimmune disease.

  1987cited by this paper
• Functional characterization of an antigen involved in an early step of T-cell activation.

  1987cited by this paper
• Antilymphocyte antibodies and systemic lupus erythematosus.

  1987cited by this paper
• A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.

  1987cited by this paper
• Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o- tetradecanoyl phorbol-13-acetate, mitogens, and antigens

  1986cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• Anti-β2-Microglobulin Lymphocytotoxic Autoantibodies in Systemic Lupus Erythematosus

  1979cited by this paper
• Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.

  1979cited by this paper
• Anti-beta2-microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus.

  1979cited by this paper
• [Criteria of diagnosis of Behcet's disease].

  1975cited by this paper
• [Rheumatoid factors].

  1971cited by this paper

• Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis

  2021cites this paper
• Megalin/lipoprotein receptor-related protein 2 autoimmunity and kidney disease

  2020cites this paper
• Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  2018cites this paper
• Is CD69 an effective brake to control inflammatory diseases?

  2013cites this paper
• [Novel methods of cytokine detection: real-time PCR, ELISPOT, and intracellular cytokine staining].

  2009cites this paper
• Marginal zone B-cell precursors as cellular agents for type I IFN promoted antigen transport

  2009cites this paper
• The complexity in hunting for candidate genes within QTL that determine susceptibility to arthritis in rats.

  2008cites this paper
• CrossLinking of the CD69 Molecule Enhances S100A9 Production in Activated Neutrophils

  2007cites this paper
• Proteomic Surveillance of Autoantigens in Relapsing Polychondritis

  2006cites this paper
• [Antireceptor and antichannel autoantibodies].

  2006cites this paper
• Autoanticorps antirécepteurs et autoanticorps anticanaux transmembranaires. Partie 1

  2006cites this paper
• CD69 is an immunoregulatory molecule induced following activation.

  2005cites this paper
• CD69 expression on neutrophils from patients with rheumatoid arthritis.

  2004cites this paper
• Characterisation of cartilage intermediate layer protein (CILP)-induced arthropathy in mice

  2004cites this paper
• Identification of diseases that may be targets for complementary and alternative medicine (CAM).

  2004cites this paper
• Regulation immunitaire basee sur le ciblage de molecules d'activation precoce

  2004cites this paper
• CD 69 downregulates autoimmune reactivity through active transforming growth factor-β production in collagen-induced arthritis

  2003cites this paper
• Infections, Toxic Chemicals and Dietary Peptides Binding to Lymphocyte Receptors and Tissue Enzymes are Major Instigators of Autoimmunity in Autism

  2003cites this paper
• Autoantibodies to CD69 in Patients with Chronic Hepatitis Type C: A Candidate Marker for Predicting the Response to Interferon Therapy

  2003cites this paper
• Autoantibodies to low-density-lipoprotein-receptor-related protein 2 (LRP2) in systemic autoimmune diseases

  2003cites this paper
• CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis.

  2003cites this paper
• Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-γ, and IFN-α

  2002cites this paper
• Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-gamma, and IFN-alpha.

  2002cites this paper